Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
40
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Feltquate David | Chief Medical Officer | 3 | $0 | $0 | 2025-08-29 |
| Lee David K | Director | 4 | $0 | $0 | 2025-08-29 |
| McGrath Yvonne | VP, Research and Development | 34 | $0 | $1.23M | 2025-08-29 |
| Call Matthew | Chief Operating Officer | 19 | $0 | $0 | 2025-08-29 |
| Detheux Michel | Chief Executive Officer | 113 | $0 | $10.04M | 2025-08-29 |
| Gall Matthew | Chief Financial Officer | 20 | $210.9K | $232.3K | 2025-08-29 |
| Hallal David | Director | 34 | $0 | $3.94M | 2025-08-29 |
| RHOADS ANN D | Director | 7 | $0 | $0 | 2025-08-29 |
| EcoR1 Capital, LLC | 10% Owner | 2 | $38.69M | $0 | 2025-05-15 |
| MPM BioVentures 2018 GP LLC | Other | 37 | $0 | $21.67M | 2025-05-13 |
| Van Hauwermeiren Timothy | Director | 8 | $0 | $0 | 2025-05-13 |
| MPM BIOVENTURES 2018 (B), L.P. | Other | 18 | $0 | $8.81M | 2025-05-13 |
| MPM Oncology Impact Management LP | Other | 21 | $0 | $18.14M | 2025-05-13 |
| DeSimone Jill | Director | 2 | $0 | $0 | 2024-06-11 |
| Iannone Robert | Director | 5 | $0 | $0 | 2024-06-11 |
| Ho Tony W | Director | 5 | $0 | $0 | 2024-06-11 |
| Davis Aaron I. | Other | 31 | $28.70M | $29.89M | 2024-06-11 |
| Kolchinsky Peter | Other | 3 | $100.00M | $0 | 2024-05-12 |
| DiRocco Derek | Director | 5 | $0 | $0 | 2023-06-13 |
| Lager Joanne Jenkins | Chief Medical Officer | 27 | $0 | $2.13M | 2023-03-09 |
| RODEN MATTHEW | Director | 3 | $0 | $0 | 2022-06-09 |
| Biniszkiewicz Detlev | Director | 7 | $0 | $181.7K | 2022-06-09 |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 3 | $0 | $0 | 2022-06-09 |
| Boxer Capital, LLC | 10% Owner | 1 | $0 | $20.28M | 2022-03-17 |
| MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | 10% Owner | 11 | $0 | $7.02M | 2022-01-05 |
| GADICKE ANSBERT | Director, 10% Owner | 18 | $0 | $17.96M | 2022-01-05 |
| MVA Investors, LLC | 10% Owner | 14 | $0 | $32.58M | 2022-01-04 |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | 20 | $0 | $6.01M | 2021-12-07 |
| Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | 35 | $0 | $18.47M | 2021-12-07 |
| MPM BioVentures 2018 LLC | 10% Owner | 19 | $0 | $6.52M | 2021-12-02 |
| EVNIN LUKE | 10% Owner | 25 | $0 | $9.58M | 2021-12-02 |
| MPM BioVentures 2014, L.P. | 10% Owner | 41 | $3.04M | $3.28M | 2021-10-18 |
| Foley Todd | 10% Owner | 7 | $0 | $4.01M | 2021-10-11 |
| MPM BioVentures 2014 LLC | 10% Owner | 2 | $0 | $580.7K | 2021-09-30 |
| UBS Oncology Impact Fund L.P. | 10% Owner | 4 | $0 | $2.48M | 2021-09-27 |
| MPM Asset Management Investors BV2014 LLC | 10% Owner | 2 | $0 | $933.0K | 2021-09-22 |
| MPM BioVentures 2014 GP LLC | 10% Owner | 30 | $3.04M | $0 | 2020-07-28 |
| MPM Oncology Impact Management GP LLC | Other | 35 | $6.08M | $0 | 2020-07-28 |
| Shah Rajeev M. | 10% Owner | 3 | $27.07M | $0 | 2020-07-28 |
| Boxer Asset Management Inc. | 10% Owner | 6 | $27.07M | $0 | 2020-07-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| RHOADS ANN D | Director | D To issuer deriv | 2025-08-29 | 2025-08-29 | 27,178 | — | $0 | 0 | SEC↗ |
| Hallal David | Director | D To issuer deriv | 2025-08-29 | 2025-08-29 | 25,140 | — | $0 | 0 | SEC↗ |
| Hallal David | Director | D To issuer deriv | 2025-08-29 | 2025-08-29 | 146,160 | — | $0 | 0 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 91,000 | — | $0 | 0 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 69,069 | — | $0 | 0 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 16,054 | — | $0 | 0 | SEC↗ |
| Gall Matthew | Chief Financial Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 135,937 | — | $0 | 0 | SEC↗ |
| Gall Matthew | Chief Financial Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 42,388 | — | $0 | 0 | SEC↗ |
| Gall Matthew | Chief Financial Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 8,123 | — | $0 | 0 | SEC↗ |
| Gall Matthew | Chief Financial Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 252,135 | — | $0 | 0 | SEC↗ |
| Gall Matthew | Chief Financial Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 9,063 | — | $0 | 0 | SEC↗ |
| Lee David K | Director | D To issuer deriv | 2025-08-29 | 2025-08-29 | 21,141 | — | $0 | 0 | SEC↗ |
| Lee David K | Director | D To issuer deriv | 2025-08-29 | 2025-08-29 | 23,625 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 14,185 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 444,815 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 94,336 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 50,128 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 52,700 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 185,000 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 17,544 | — | $0 | 0 | SEC↗ |
| Call Matthew | Chief Operating Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 9,063 | — | $0 | 0 | SEC↗ |
| Call Matthew | Chief Operating Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 135,937 | — | $0 | 0 | SEC↗ |
| Call Matthew | Chief Operating Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 66,170 | — | $0 | 0 | SEC↗ |
| Call Matthew | Chief Operating Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 41,694 | — | $0 | 0 | SEC↗ |
| Call Matthew | Chief Operating Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 17,074 | — | $0 | 0 | SEC↗ |
| Call Matthew | Chief Operating Officer | D To issuer deriv | 2025-08-29 | 2025-08-29 | 146,835 | — | $0 | 0 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | U Tender | 2025-08-29 | 2025-08-29 | 46,300 | — | $0 | 0 | SEC↗ |
| Gall Matthew | Chief Financial Officer | U Tender | 2025-08-29 | 2025-08-29 | 89,429 | — | $0 | 0 | SEC↗ |
| Feltquate David | Chief Medical Officer | U Tender | 2025-08-29 | 2025-08-29 | 47,000 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | U Tender | 2025-08-29 | 2025-08-29 | 153,903 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | U Tender | 2025-08-29 | 2025-08-29 | 94,027 | — | $0 | 0 | SEC↗ |
| Call Matthew | Chief Operating Officer | U Tender | 2025-08-29 | 2025-08-29 | 161,898 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-10 | 2025-06-11 | 8,400 | — | $0 | 18,000 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-10 | 2025-06-11 | 94,027 | — | $0 | 3 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-10 | 2025-06-11 | 18,000 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-10 | 2025-06-11 | 43,883 | — | $0 | 94,030 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-10 | 2025-06-11 | 43,883 | $10.02 | $439.7K | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-10 | 2025-06-11 | 18,000 | $4.30 | $77.4K | 153,903 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-10 | 2025-06-11 | 94,027 | $4.30 | $404.3K | 94,027 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-10 | 2025-06-11 | 8,400 | $10.02 | $84.2K | 135,903 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-10 | 2025-06-11 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-10 | 2025-06-11 | 43,883 | $4.30 | $188.7K | 43,883 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-09 | 2025-06-11 | 43,882 | — | $0 | 137,913 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-09 | 2025-06-11 | 8,400 | — | $0 | 26,400 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-09 | 2025-06-11 | 43,882 | $10.03 | $440.1K | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-09 | 2025-06-11 | 43,882 | $4.30 | $188.7K | 43,882 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-09 | 2025-06-11 | 8,400 | $10.03 | $84.3K | 135,903 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-09 | 2025-06-11 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2025-06-06 | 2025-06-06 | 38,228 | — | $0 | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-06 | 2025-06-06 | 43,882 | — | $0 | 181,795 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-06 | 2025-06-06 | 8,400 | — | $0 | 34,800 | SEC↗ |
| Hallal David | Director | S Sale | 2025-06-06 | 2025-06-06 | 38,228 | $10.24 | $391.5K | 0 | SEC↗ |
| Hallal David | Director | M Exercise | 2025-06-06 | 2025-06-06 | 38,228 | $4.30 | $164.4K | 38,228 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-06 | 2025-06-06 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-06 | 2025-06-06 | 8,400 | $10.21 | $85.8K | 135,903 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-06 | 2025-06-06 | 43,882 | $4.30 | $188.7K | 43,882 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-06 | 2025-06-06 | 43,882 | $10.21 | $448.0K | 0 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2025-06-05 | 2025-06-06 | 38,227 | — | $0 | 38,228 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-05 | 2025-06-06 | 43,882 | — | $0 | 225,677 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-05 | 2025-06-06 | 8,400 | — | $0 | 43,200 | SEC↗ |
| Hallal David | Director | S Sale | 2025-06-05 | 2025-06-06 | 38,227 | $10.15 | $388.0K | 0 | SEC↗ |
| Hallal David | Director | M Exercise | 2025-06-05 | 2025-06-06 | 38,227 | $4.30 | $164.4K | 38,227 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-05 | 2025-06-06 | 43,882 | $10.15 | $445.4K | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-05 | 2025-06-06 | 43,882 | $4.30 | $188.7K | 43,882 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-05 | 2025-06-06 | 8,400 | $10.15 | $85.3K | 135,903 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-05 | 2025-06-06 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2025-06-04 | 2025-06-06 | 38,227 | — | $0 | 76,455 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-04 | 2025-06-06 | 8,400 | — | $0 | 51,600 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2025-06-04 | 2025-06-06 | 43,883 | — | $0 | 269,559 | SEC↗ |
| Hallal David | Director | S Sale | 2025-06-04 | 2025-06-06 | 38,227 | $10.07 | $384.9K | 0 | SEC↗ |
| Hallal David | Director | M Exercise | 2025-06-04 | 2025-06-06 | 38,227 | $4.30 | $164.4K | 38,227 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-04 | 2025-06-06 | 43,883 | $10.10 | $443.2K | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-04 | 2025-06-06 | 43,883 | $4.30 | $188.7K | 43,883 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2025-06-04 | 2025-06-06 | 8,400 | $10.10 | $84.8K | 135,903 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2025-06-04 | 2025-06-06 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| EcoR1 Capital, LLC | 10% Owner | P Buy | 2025-05-15 | 2025-05-16 | 3,300,000 | $8.00 | $26.40M | 10,688,978 | SEC↗ |
| EcoR1 Capital, LLC | 10% Owner | P Buy | 2025-05-14 | 2025-05-16 | 1,658,978 | $7.41 | $12.29M | 7,388,978 | SEC↗ |
| Van Hauwermeiren Timothy | Director | M Exercise deriv | 2025-05-13 | 2025-05-14 | 22,346 | — | $0 | 0 | SEC↗ |
| Van Hauwermeiren Timothy | Director | M Exercise | 2025-05-13 | 2025-05-14 | 22,346 | $4.30 | $96.1K | 22,346 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | Other | S Sale | 2025-05-13 | 2025-05-15 | 630,191 | $8.06 | $5.08M | 2,108,594 | SEC↗ |
| MPM BioVentures 2018 GP LLC | Other | S Sale | 2025-05-13 | 2025-05-15 | 630,191 | $8.06 | $5.08M | 2,108,594 | SEC↗ |
| MPM BioImpact LLC | Other | S Sale | 2025-05-13 | 2025-05-15 | 1,031,931 | $8.06 | $8.32M | 3,452,797 | SEC↗ |
| Gall Matthew | Chief Financial Officer | A Award deriv | 2025-03-07 | 2025-03-11 | 145,000 | — | $0 | 145,000 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | A Award deriv | 2025-03-07 | 2025-03-11 | 91,000 | — | $0 | 91,000 | SEC↗ |
| Detheux Michel | Chief Executive Officer | A Award deriv | 2025-03-07 | 2025-03-11 | 459,000 | — | $0 | 459,000 | SEC↗ |
| Call Matthew | Chief Operating Officer | A Award deriv | 2025-03-07 | 2025-03-11 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Gall Matthew | Chief Financial Officer | A Award | 2025-03-07 | 2025-03-11 | 24,000 | — | $0 | 89,429 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | A Award | 2025-03-07 | 2025-03-11 | 15,300 | — | $0 | 46,300 | SEC↗ |
| Detheux Michel | Chief Executive Officer | A Award | 2025-03-07 | 2025-03-11 | 77,000 | — | $0 | 135,903 | SEC↗ |
| Call Matthew | Chief Operating Officer | A Award | 2025-03-07 | 2025-03-11 | 24,000 | — | $0 | 161,898 | SEC↗ |
| Feltquate David | Chief Medical Officer | A Award | 2024-12-06 | 2024-12-06 | 47,000 | — | $0 | 47,000 | SEC↗ |
| Gall Matthew | Chief Financial Officer | P Buy | 2024-11-19 | 2024-11-19 | 5,000 | $7.73 | $38.6K | 65,429 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2024-08-08 | 2024-08-09 | 442,800 | — | $0 | 442,800 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2024-08-08 | 2024-08-09 | 442,800 | — | $0 | 147,600 | SEC↗ |
| Feltquate David | Chief Medical Officer | A Award deriv | 2024-08-01 | 2024-08-05 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Iannone Robert | Director | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| RHOADS ANN D | Director | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| Hallal David | Director | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| DeSimone Jill | Director | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| Davis Aaron I. | Director | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| Lee David K | Director | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| Van Hauwermeiren Timothy | Director | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| Ho Tony W | Director | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| Kolchinsky Peter | Other | J Other deriv | 2024-05-12 | 2024-05-14 | 900,000 | — | $0 | 6,614,285 | SEC↗ |
| Kolchinsky Peter | Other | J Other | 2024-05-12 | 2024-05-14 | 900,000 | — | $0 | 2,545,510 | SEC↗ |
| Kolchinsky Peter | Other | P Buy deriv | 2024-05-10 | 2024-05-14 | 5,714,285 | $17.50 | $100.00M | 5,714,285 | SEC↗ |
| Davis Aaron I. | A Award | 2024-05-10 | 2024-05-14 | 1,142,857 | $17.50 | $20.00M | 2,946,915 | SEC↗ | |
| DeSimone Jill | Director | A Award deriv | 2024-03-07 | 2024-03-07 | 44,766 | — | $0 | 44,766 | SEC↗ |
| Detheux Michel | Chief Executive Officer | A Award deriv | 2024-03-07 | 2024-03-08 | 590,400 | — | $0 | 590,400 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | A Award deriv | 2024-03-07 | 2024-03-08 | 153,600 | — | $0 | 153,600 | SEC↗ |
| Call Matthew | Chief Operating Officer | A Award deriv | 2024-03-07 | 2024-03-08 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Gall Matthew | Chief Financial Officer | A Award deriv | 2024-03-07 | 2024-03-08 | 163,200 | — | $0 | 163,200 | SEC↗ |
| Lee David K | Director | A Award deriv | 2023-12-05 | 2023-12-07 | 44,766 | — | $0 | 44,766 | SEC↗ |
| Detheux Michel | Chief Executive Officer | A Award | 2023-12-05 | 2023-12-07 | 30,000 | — | $0 | 58,903 | SEC↗ |
| Gall Matthew | Chief Financial Officer | A Award | 2023-12-05 | 2023-12-07 | 41,000 | — | $0 | 60,429 | SEC↗ |
| Call Matthew | Chief Operating Officer | A Award | 2023-12-05 | 2023-12-07 | 44,000 | — | $0 | 137,898 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | A Award | 2023-12-05 | 2023-12-07 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Gall Matthew | Chief Financial Officer | P Buy | 2023-10-12 | 2023-10-12 | 5,000 | $8.37 | $41.8K | 19,429 | SEC↗ |
| Davis Aaron I. | Other | S Sale | 2023-08-23 | 2023-08-25 | 219,638 | $16.87 | $3.71M | 1,804,058 | SEC↗ |
| Davis Aaron I. | Other | S Sale | 2023-08-23 | 2023-08-25 | 95,516 | $15.63 | $1.49M | 2,023,696 | SEC↗ |
| Davis Aaron I. | Other | S Sale | 2023-08-23 | 2023-08-25 | 34,846 | $14.19 | $494.5K | 2,119,212 | SEC↗ |
| Davis Aaron I. | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| DiRocco Derek | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| Hallal David | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| Ho Tony W | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| Iannone Robert | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| RHOADS ANN D | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| Van Hauwermeiren Timothy | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| Call Matthew | Chief Operating Officer | M Exercise deriv | 2023-03-28 | 2023-03-29 | 40,226 | — | $0 | 107,864 | SEC↗ |
| Call Matthew | Chief Operating Officer | M Exercise | 2023-03-28 | 2023-03-29 | 40,226 | $2.95 | $118.7K | 93,898 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2023-03-09 | 2023-03-10 | 254,997 | — | $0 | 254,997 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2023-03-09 | 2023-03-10 | 254,997 | — | $0 | 91,003 | SEC↗ |
| Detheux Michel | Chief Executive Officer | A Award deriv | 2023-03-09 | 2023-03-10 | 346,000 | — | $0 | 346,000 | SEC↗ |
| Call Matthew | Chief Operating Officer | A Award deriv | 2023-03-09 | 2023-03-10 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Gall Matthew | Chief Financial Officer | A Award deriv | 2023-03-09 | 2023-03-10 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | A Award deriv | 2023-03-09 | 2023-03-10 | 130,000 | — | $0 | 130,000 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | A Award deriv | 2023-03-09 | 2023-03-10 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Biniszkiewicz Detlev | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| Davis Aaron I. | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| DiRocco Derek | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2022-06-09 | 2022-06-10 | 1,171 | — | $0 | 146,160 | SEC↗ |
| Hallal David | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| Ho Tony W | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| Iannone Robert | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| RHOADS ANN D | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| RODEN MATTHEW | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| Van Hauwermeiren Timothy | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| Hallal David | Director | S Sale | 2022-06-09 | 2022-06-10 | 1,171 | $19.51 | $22.8K | 0 | SEC↗ |
| Hallal David | Director | M Exercise | 2022-06-09 | 2022-06-10 | 1,171 | $4.23 | $5.0K | 1,171 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2022-06-08 | 2022-06-10 | 5,968 | — | $0 | 157,908 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2022-06-08 | 2022-06-10 | 11,899 | — | $0 | 25,140 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2022-06-08 | 2022-06-10 | 10,577 | — | $0 | 147,331 | SEC↗ |
| Hallal David | Director | M Exercise | 2022-06-08 | 2022-06-10 | 11,899 | $2.95 | $35.1K | 11,899 | SEC↗ |
| Hallal David | Director | S Sale | 2022-06-08 | 2022-06-10 | 5,968 | $20.39 | $121.7K | 0 | SEC↗ |
| Hallal David | Director | M Exercise | 2022-06-08 | 2022-06-10 | 5,968 | $4.23 | $25.2K | 5,968 | SEC↗ |
| Hallal David | Director | S Sale | 2022-06-08 | 2022-06-10 | 10,577 | $19.86 | $210.1K | 0 | SEC↗ |
| Hallal David | Director | S Sale | 2022-06-08 | 2022-06-10 | 11,899 | $20.39 | $242.6K | 0 | SEC↗ |
| Hallal David | Director | M Exercise | 2022-06-08 | 2022-06-10 | 10,577 | $4.23 | $44.7K | 10,577 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-05-11 | 2022-05-11 | 337,109 | $18.25 | $6.15M | 2,154,058 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-05-11 | 2022-05-11 | 891 | $17.53 | $15.6K | 2,491,167 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-05-10 | 2022-05-11 | 95,150 | $25.18 | $2.40M | 2,496,908 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-05-10 | 2022-05-11 | 4,850 | $24.77 | $120.1K | 2,492,058 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-05-09 | 2022-05-11 | 200,000 | $23.47 | $4.69M | 2,592,058 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-05-09 | 2022-05-11 | 25,000 | $22.91 | $572.8K | 2,792,058 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-05-02 | 2022-05-02 | 7,300 | $26.91 | $196.4K | 2,909,758 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-05-02 | 2022-05-02 | 92,700 | $27.53 | $2.55M | 2,817,058 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-04-29 | 2022-05-02 | 10,000 | $28.22 | $282.2K | 3,032,058 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-04-29 | 2022-05-02 | 115,000 | $27.01 | $3.11M | 2,917,058 | SEC↗ |
| Davis Aaron I. | Director | S Sale | 2022-04-28 | 2022-05-02 | 150,000 | $27.40 | $4.11M | 3,042,058 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2022-04-18 | 2022-04-19 | 11,500 | — | $0 | 144,464 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-04-18 | 2022-04-19 | 11,467 | $31.87 | $365.5K | 26,296 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-04-18 | 2022-04-19 | 33 | $32.64 | $1.1K | 26,263 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2022-04-18 | 2022-04-19 | 11,500 | $4.23 | $48.6K | 37,763 | SEC↗ |
| Davis Aaron I. | Director | P Buy | 2022-03-23 | 2022-03-24 | 20,000 | $32.85 | $657.0K | 3,192,058 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-03-22 | 2022-03-22 | 9,908 | $34.11 | $338.0K | 28,970 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-03-22 | 2022-03-22 | 1,159 | $35.22 | $40.8K | 27,811 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-03-22 | 2022-03-22 | 1,548 | $36.51 | $56.5K | 26,263 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-03-22 | 2022-03-22 | 5,822 | $33.44 | $194.7K | 38,878 | SEC↗ |
| Davis Aaron I. | Director | P Buy | 2022-03-22 | 2022-03-24 | 21,300 | $31.88 | $679.0K | 3,163,358 | SEC↗ |
| Davis Aaron I. | Director | P Buy | 2022-03-22 | 2022-03-24 | 3,700 | $33.09 | $122.4K | 3,167,058 | SEC↗ |
| Davis Aaron I. | Director | P Buy | 2022-03-22 | 2022-03-24 | 5,000 | $33.43 | $167.2K | 3,172,058 | SEC↗ |
| Boxer Capital, LLC | 10% Owner | S Sale | 2022-03-17 | 2022-03-18 | 575,201 | $35.25 | $20.28M | 3,142,058 | SEC↗ |
| Call Matthew | Chief Operating Officer | A Award deriv | 2022-03-11 | 2022-03-14 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Detheux Michel | Chief Executive Officer | A Award deriv | 2022-03-11 | 2022-03-14 | 352,500 | — | $0 | 352,500 | SEC↗ |
| Gall Matthew | Chief Financial Officer | A Award deriv | 2022-03-11 | 2022-03-14 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | A Award deriv | 2022-03-11 | 2022-03-14 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise deriv | 2022-03-11 | 2022-03-14 | 3,500 | — | $0 | 178,938 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | A Award deriv | 2022-03-11 | 2022-03-14 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Detheux Michel | Chief Executive Officer | A Award | 2022-03-11 | 2022-03-14 | 10,000 | — | $0 | 44,700 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise | 2022-03-11 | 2022-03-14 | 3,500 | $4.30 | $15.1K | 3,500 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | S Sale | 2022-03-11 | 2022-03-14 | 3,500 | $36.01 | $126.0K | 0 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | M Exercise deriv | 2022-03-01 | 2022-03-02 | 10,000 | — | $0 | 85,123 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | M Exercise | 2022-03-01 | 2022-03-02 | 10,000 | $4.24 | $42.4K | 10,000 | SEC↗ |
| McGrath Yvonne | Chief Scientific Officer | S Sale | 2022-03-01 | 2022-03-02 | 10,000 | $36.76 | $367.6K | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-02-23 | 2022-02-24 | 13,956 | $34.30 | $478.7K | 35,244 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-02-23 | 2022-02-24 | 544 | $35.32 | $19.2K | 34,700 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise deriv | 2022-02-11 | 2022-02-14 | 3,500 | — | $0 | 182,438 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | S Sale | 2022-02-11 | 2022-02-14 | 1,982 | $35.52 | $70.4K | 1,518 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | S Sale | 2022-02-11 | 2022-02-14 | 1,518 | $36.27 | $55.1K | 0 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise | 2022-02-11 | 2022-02-14 | 3,500 | $4.30 | $15.1K | 3,500 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-01-25 | 2022-01-26 | 4,412 | $36.21 | $159.8K | 49,200 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2022-01-25 | 2022-01-26 | 10,088 | $35.45 | $357.6K | 53,612 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise deriv | 2022-01-14 | 2022-01-18 | 3,500 | — | $0 | 185,938 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | S Sale | 2022-01-14 | 2022-01-18 | 723 | $39.58 | $28.6K | 0 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | S Sale | 2022-01-14 | 2022-01-18 | 2,777 | $39.25 | $109.0K | 723 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise | 2022-01-14 | 2022-01-18 | 3,500 | $4.30 | $15.1K | 3,500 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | S Sale | 2022-01-05 | 2022-01-06 | 30,347 | $42.03 | $1.28M | 4,484,728 | SEC↗ |
| MPM ASSET MANAGEMENT INVESTORS | 10% Owner | S Sale | 2022-01-05 | 2022-01-06 | 18,135 | $42.03 | $762.2K | 2,738,785 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2022-01-05 | 2022-01-06 | 18,135 | $42.03 | $762.2K | 2,738,785 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-05 | 88,054 | $41.84 | $3.68M | 3,767,405 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-05 | 11,199 | $44.44 | $497.7K | 2,517 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-05 | 3,138 | $43.36 | $136.1K | 13,716 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-05 | 29,623 | $41.84 | $1.24M | 16,854 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-05 | 7,483 | $45.48 | $340.3K | 3,717,259 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-05 | 33,297 | $44.44 | $1.48M | 3,724,742 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-05 | 9,366 | $43.36 | $406.1K | 3,758,039 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-05 | 2,517 | $45.48 | $114.5K | 0 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 158,579 | $42.05 | $6.67M | 4,571,618 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 32,396 | $43.20 | $1.40M | 4,539,222 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 11,318 | $45.32 | $512.9K | 4,527,904 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 12,829 | $46.47 | $596.2K | 4,515,075 | SEC↗ |
| MPM ASSET MANAGEMENT INVESTORS | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 7,671 | $46.47 | $356.5K | 2,756,920 | SEC↗ |
| MPM ASSET MANAGEMENT INVESTORS | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 6,768 | $45.32 | $306.7K | 2,764,591 | SEC↗ |
| MPM ASSET MANAGEMENT INVESTORS | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 94,745 | $42.05 | $3.98M | 2,790,725 | SEC↗ |
| MPM ASSET MANAGEMENT INVESTORS | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 19,366 | $43.20 | $836.6K | 2,771,359 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 7,671 | $46.47 | $356.5K | 2,756,920 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 6,768 | $45.32 | $306.7K | 2,764,591 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 94,745 | $42.05 | $3.98M | 2,790,725 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2022-01-04 | 2022-01-06 | 19,366 | $43.20 | $836.6K | 2,771,359 | SEC↗ |
| Biniszkiewicz Detlev | Director | M Exercise deriv | 2022-01-03 | 2022-01-04 | 3,500 | — | $0 | 13,108 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise deriv | 2022-01-03 | 2022-01-04 | 7,000 | — | $0 | 189,438 | SEC↗ |
| Biniszkiewicz Detlev | Director | M Exercise | 2022-01-03 | 2022-01-04 | 3,500 | $19.00 | $66.5K | 3,500 | SEC↗ |
| Biniszkiewicz Detlev | Director | S Sale | 2022-01-03 | 2022-01-04 | 3,500 | $51.90 | $181.7K | 0 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | S Sale | 2022-01-03 | 2022-01-04 | 7,000 | $51.90 | $363.3K | 0 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise | 2022-01-03 | 2022-01-04 | 7,000 | $4.30 | $30.1K | 7,000 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 731 | $50.63 | $37.0K | 46,477 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 1,682 | $49.37 | $83.0K | 47,208 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 23,353 | $47.63 | $1.11M | 48,890 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 17,173 | $50.63 | $869.5K | 3,855,459 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 39,481 | $49.37 | $1.95M | 3,872,632 | SEC↗ |
| MVA Investors, LLC | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 432,903 | $47.65 | $20.63M | 3,912,113 | SEC↗ |
| Gall Matthew | Chief Financial Officer | S Sale | 2021-12-27 | 2021-12-28 | 5,000 | $46.45 | $232.3K | 14,429 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2021-12-22 | 2021-12-22 | 1,663 | — | $0 | 60,000 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2021-12-22 | 2021-12-22 | 1,663 | $4.30 | $7.2K | 79,863 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2021-12-22 | 2021-12-22 | 149 | $44.92 | $6.7K | 78,200 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2021-12-22 | 2021-12-22 | 5,007 | $44.62 | $223.4K | 73,193 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2021-12-22 | 2021-12-22 | 9,493 | $45.37 | $430.7K | 63,700 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2021-12-22 | 2021-12-22 | 1,514 | $44.31 | $67.1K | 78,349 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2021-12-21 | 2021-12-22 | 19,226 | — | $0 | 61,663 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2021-12-21 | 2021-12-22 | 13,646 | $44.15 | $602.5K | 83,780 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2021-12-21 | 2021-12-22 | 5,580 | $45.06 | $251.4K | 78,200 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2021-12-21 | 2021-12-22 | 19,226 | $4.30 | $82.7K | 97,426 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2021-12-20 | 2021-12-22 | 30,000 | — | $0 | 37,039 | SEC↗ |
| Hallal David | Director | M Exercise deriv | 2021-12-20 | 2021-12-22 | 20,000 | — | $0 | 114,682 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise deriv | 2021-12-20 | 2021-12-22 | 9,111 | — | $0 | 80,889 | SEC↗ |
| Hallal David | Director | M Exercise | 2021-12-20 | 2021-12-22 | 20,000 | $4.30 | $86.0K | 20,000 | SEC↗ |
| Hallal David | Director | M Exercise | 2021-12-20 | 2021-12-22 | 30,000 | $2.95 | $88.5K | 50,000 | SEC↗ |
| Hallal David | Director | S Sale | 2021-12-20 | 2021-12-22 | 50,000 | $43.57 | $2.18M | 0 | SEC↗ |
| Detheux Michel | Chief Executive Officer | M Exercise | 2021-12-20 | 2021-12-22 | 9,111 | $4.30 | $39.2K | 87,311 | SEC↗ |
| Detheux Michel | Chief Executive Officer | S Sale | 2021-12-20 | 2021-12-22 | 9,111 | $43.94 | $400.3K | 78,200 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise deriv | 2021-12-17 | 2021-12-17 | 7,000 | — | $0 | 196,438 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise | 2021-12-17 | 2021-12-17 | 7,000 | $4.30 | $30.1K | 7,000 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | S Sale | 2021-12-17 | 2021-12-17 | 7,000 | $41.00 | $287.0K | 0 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise deriv | 2021-12-10 | 2021-12-10 | 3,500 | — | $0 | 203,438 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | M Exercise | 2021-12-10 | 2021-12-10 | 3,500 | $4.30 | $15.1K | 3,500 | SEC↗ |
| Lager Joanne Jenkins | Chief Medical Officer | S Sale | 2021-12-10 | 2021-12-10 | 3,500 | $34.50 | $120.8K | 0 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-07 | 2021-12-07 | 30,059 | $33.15 | $996.5K | 4,732,696 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-07 | 2021-12-07 | 2,499 | $34.11 | $85.2K | 4,730,197 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-07 | 2021-12-07 | 17,962 | $33.15 | $595.4K | 2,886,964 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-07 | 2021-12-07 | 1,494 | $34.11 | $51.0K | 2,885,470 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-07 | 2021-12-07 | 17,962 | $33.15 | $595.4K | 2,886,964 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-07 | 2021-12-07 | 1,494 | $34.11 | $51.0K | 2,885,470 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 100 | $35.04 | $3.5K | 4,762,755 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 850 | $34.08 | $29.0K | 4,762,855 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 1,960 | $33.57 | $65.8K | 4,763,705 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 14,173 | $32.35 | $458.5K | 4,765,665 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 60 | $35.04 | $2.1K | 2,904,926 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 508 | $34.08 | $17.3K | 2,904,986 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 8,469 | $32.35 | $274.0K | 2,906,665 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 1,171 | $33.57 | $39.3K | 2,905,494 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 1,171 | $33.57 | $39.3K | 2,905,494 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 60 | $35.04 | $2.1K | 2,904,926 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 508 | $34.08 | $17.3K | 2,904,986 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-06 | 2021-12-07 | 8,469 | $32.35 | $274.0K | 2,906,665 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 300 | $36.26 | $10.9K | 4,779,838 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 4,047 | $35.44 | $143.4K | 4,780,138 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 29,402 | $34.68 | $1.02M | 4,784,185 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 2,419 | $35.44 | $85.7K | 2,915,313 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 179 | $36.26 | $6.5K | 2,915,134 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 17,569 | $34.68 | $609.3K | 2,917,732 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 179 | $36.26 | $6.5K | 2,915,134 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 2,419 | $35.44 | $85.7K | 2,915,313 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2021-12-03 | 2021-12-07 | 17,569 | $34.68 | $609.3K | 2,917,732 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2021-12-02 | 2021-12-22 | 313,442 | — | $0 | 90,000 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2021-12-02 | 2021-12-22 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2021-12-02 | 2021-12-22 | 185,000 | — | $0 | 155,964 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2021-12-02 | 2021-12-22 | 313,442 | — | $0 | 313,442 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2021-12-02 | 2021-12-22 | 106,200 | — | $0 | 106,200 | SEC↗ |
| Detheux Michel | Chief Executive Officer | G Gift deriv | 2021-12-02 | 2021-12-22 | 106,200 | — | $0 | 37,800 | SEC↗ |